IP Verse

Amerigen Pharmaceuticals Limited et al. vs UCB Pharma GmbH

The detailed information for PTAB case with proceeding number IPR2016-01665 filed by Amerigen Pharmaceuticals Limited et al. against UCB Pharma GmbH on Aug 22, 2016. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2016-01665
Filing Date: Aug 22, 2016
Petitioner: Amerigen Pharmaceuticals Limited et al.
Respondent: UCB Pharma GmbH
Status: Final Written Decision
Respondent Application Number: 10130214
Respondent Tech Center: 1600
Respondent Patent Number: 6858650
Institution Decision Date: Dec 7, 2016
Termination Date: Jul 19, 2017

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
CAFC Decision - Entered 1/11/19	Apr 22, 2019	PAPER	BOARD
CAFC Mandate	Apr 22, 2019	PAPER	BOARD
Notice of Appeal	Sep 20, 2017	PAPER	PETITIONER
FINAL WRITTEN DECISION - Finding Claims 1–5 and 21–24 Not Unpatentable - Dismissing as Moot Patent Owner’s Motion to Exclude - Granting Joint Motion to Seal and Entering Default Protective Order	Jul 19, 2017	PAPER	BOARD
Trial Instituted Document	Dec 7, 2016	PAPER	BOARD
Patent Owner Mandatory Notice Information	Sep 9, 2016	PAPER	PATENT OWNER
Patent Owner Power of Attorney	Sep 9, 2016	PAPER	PATENT OWNER
Notice of Accord Filing Date	Aug 29, 2016	PAPER	BOARD
Petition	Aug 22, 2016	PAPER	PETITIONER
Motion for Joinder	Aug 22, 2016	PAPER	PETITIONER
1001 U.S.P.N. 6,858,650	Aug 22, 2016	EXHIBIT	PETITIONER
1003 Declaration of Steven E. Patterson, Ph.D	Aug 22, 2016	EXHIBIT	PETITIONER
1004 C.V. for Dr. Steven Patterson, Ph.D	Aug 22, 2016	EXHIBIT	PETITIONER
1007 Brynne 1997	Aug 22, 2016	EXHIBIT	PETITIONER
1008 Thomas British Heart Journal 1995	Aug 22, 2016	EXHIBIT	PETITIONER
1010 Postlind Drug Metabolism and Disposition 1998	Aug 22, 2016	EXHIBIT	PETITIONER
1011 Brynne 1998	Aug 22, 2016	EXHIBIT	PETITIONER
1013 Berge 1977.	Aug 22, 2016	EXHIBIT	PETITIONER
1015 Nilvebrant Pharmacology and Toxicology 1997	Aug 22, 2016	EXHIBIT	PETITIONER
1016 DeMaagd 2012	Aug 22, 2016	EXHIBIT	PETITIONER
1017 Appell - Urology 1997	Aug 22, 2016	EXHIBIT	PETITIONER
1019 Lipinski - Advanced Drug Delivery Reviews 1997	Aug 22, 2016	EXHIBIT	PETITIONER
Power of Attorney	Aug 22, 2016	PAPER	PETITIONER
Certificate of Word Count	Aug 22, 2016	PAPER	PETITIONER
1002 File History for U.S.P.N. 6,858,650 - Part 1	Aug 22, 2016	EXHIBIT	PETITIONER
1005 Johansson WO 9411337	Aug 22, 2016	EXHIBIT	PETITIONER
1006 Andersson Review BJU International 1999	Aug 22, 2016	EXHIBIT	PETITIONER
1009 Detrol Label Pharmacia and Upjohn	Aug 22, 2016	EXHIBIT	PETITIONER
1012 Bundgaard Design of Prodrugs 1985 - Part 1	Aug 22, 2016	EXHIBIT	PETITIONER
1014 Anderson 1998	Aug 22, 2016	EXHIBIT	PETITIONER
1018 Ashworth - Home Care Provider 1997	Aug 22, 2016	EXHIBIT	PETITIONER
1020 Bundgaard - WO 9208459	Aug 22, 2016	EXHIBIT	PETITIONER
1021 AUA Guideline	Aug 22, 2016	EXHIBIT	PETITIONER
1022 Pfizer 2012 Press Release	Aug 22, 2016	EXHIBIT	PETITIONER
1023 PM360 - April 1, 2012 Overactive Bladder Market	Aug 22, 2016	EXHIBIT	PETITIONER
1024 Toviaz Label - Pfizer Labs	Aug 22, 2016	EXHIBIT	PETITIONER
1025 FDA Approval Letter - NDA20-771	Aug 22, 2016	EXHIBIT	PETITIONER
1031 Begley 1996	Aug 22, 2016	EXHIBIT	PETITIONER
1033 Declaration of DeForest McDuff, Ph.D.	Aug 22, 2016	EXHIBIT	PETITIONER
1034 CV for DeForest McDuff, Ph.D.	Aug 22, 2016	EXHIBIT	PETITIONER
1037 U.S. OAB Prescriptions and Shares by Drug 2008-2014	Aug 22, 2016	EXHIBIT	PETITIONER
1043 Comparison of Toviaz Sales to Compound to Pharmaceutical Industry	Aug 22, 2016	EXHIBIT	PETITIONER
1026 FDA Guidance - October 1999	Aug 22, 2016	EXHIBIT	PETITIONER
1027 Gould - International Journal of Pharmaceutics 1986	Aug 22, 2016	EXHIBIT	PETITIONER
1028 Alabaster 1997	Aug 22, 2016	EXHIBIT	PETITIONER
1029 Takeuchi 1997	Aug 22, 2016	EXHIBIT	PETITIONER
1030 Goldberg 1997	Aug 22, 2016	EXHIBIT	PETITIONER
1032 Dkt 6 2015-01-28 Summons 15-cv-00079, Pfizer,et al v Mylan Pharm	Aug 22, 2016	EXHIBIT	PETITIONER
1035 Toviaz - Don't Let Overactive Bladder Stop You In Your Tracks	Aug 22, 2016	EXHIBIT	PETITIONER
1036 Toviaz U.S. and Worldwide Sales	Aug 22, 2016	EXHIBIT	PETITIONER
1038 U.S. OAB Sales and Shares by Drug 2008-2014	Aug 22, 2016	EXHIBIT	PETITIONER
1039 U.S. OAB Market Share Prescriptions and Sales by Drug 2000-2007	Aug 22, 2016	EXHIBIT	PETITIONER
1040 Prescription Path of Toviaz and Other OABs	Aug 22, 2016	EXHIBIT	PETITIONER
1041 Sales Path of Toviaz and Other OABs	Aug 22, 2016	EXHIBIT	PETITIONER
1042 Sales Path of Toviaz Compound to Pharmaceutical Industry Benchmarks	Aug 22, 2016	EXHIBIT	PETITIONER
1044 Chart of Sales Path of Toviaz	Aug 22, 2016	EXHIBIT	PETITIONER
1046 Present Value of Toviaz Worldwide Sales	Aug 22, 2016	EXHIBIT	PETITIONER
1002 File History for U.S.P.N. 6,858,650 - Part 2	Aug 22, 2016	EXHIBIT	PETITIONER
1002 File History for U.S.P.N. 6,858,650 - Part 4	Aug 22, 2016	EXHIBIT	PETITIONER
1012 Bundgaard Design of Prodrugs 1985 - Part 2	Aug 22, 2016	EXHIBIT	PETITIONER
1012 Bundgaard Design of Prodrugs 1985 - Part 3	Aug 22, 2016	EXHIBIT	PETITIONER
1012 Bundgaard Design of Prodrugs 1985 - Part 4	Aug 22, 2016	EXHIBIT	PETITIONER
1045 Present Value of Toviaz U.S. Sales	Aug 22, 2016	EXHIBIT	PETITIONER
1047 Estimates of Expected RandD Costs	Aug 22, 2016	EXHIBIT	PETITIONER
1048 U.S. OAB Detail Shares by Drug 2008-2015	Aug 22, 2016	EXHIBIT	PETITIONER
1049 Consumer Price Index	Aug 22, 2016	EXHIBIT	PETITIONER
1002 File History for U.S.P.N. 6,858,650 - Part 3	Aug 22, 2016	EXHIBIT	PETITIONER